These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3530798)

  • 1. Myeloma proteins.
    Potter M
    Experientia; 1986 Sep; 42(9):967-70. PubMed ID: 3530798
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiotype-binding cells in plasmacytoma-bearing mice.
    Serban D; Ran M; Witz IP
    Cell Immunol; 1979 Apr; 44(1):1-8. PubMed ID: 313254
    [No Abstract]   [Full Text] [Related]  

  • 3. Specific antigens inhibit plasmacytoma cells bearing phosphorylcholine-binding myeloma proteins.
    Kim BS; Rowley DA; Mallat L
    Cell Immunol; 1978 Dec; 41(2):286-93. PubMed ID: 83200
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor immunity to murine plasma cell tumors. V. Demonstration of a unique tumor antigen that is not associated with the myeloma idiotype.
    MacKenzie MR; Burton RC; Warner NL
    Int J Cancer; 1978 Jun; 21(6):789-95. PubMed ID: 78916
    [No Abstract]   [Full Text] [Related]  

  • 5. Myeloma-specific antibodies: studies of their properties and their relationship to tumor immunity.
    Frikke MJ; Bridges SH; Lynch RG
    J Immunol; 1977 Jun; 118(6):2206-12. PubMed ID: 864258
    [No Abstract]   [Full Text] [Related]  

  • 6. The idiotypic network: the murine MOPC315 anti-DNP system.
    Amor M; Mariamé B; Voegtlé D; Cazenave PA
    Ann Immunol (Paris); 1982; 133D(3):255-62. PubMed ID: 6984635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The level of expression and the molecular distribution of ABPC 48 idiotopes in levan- or anti-idiotope-primed BALB/c mice.
    Legrain P; Buttin G
    Ann N Y Acad Sci; 1983; 418():290-5. PubMed ID: 6608904
    [No Abstract]   [Full Text] [Related]  

  • 8. Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing.
    Frøyland M; Ruffini PA; Thompson KM; Gedde-Dahl T; Fredriksen AB; Bogen B
    Eur J Haematol; 2011 May; 86(5):385-95. PubMed ID: 21332794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral T cell tolerance as a tumor escape mechanism: deletion of CD4+ T cells specific for a monoclonal immunoglobulin idiotype secreted by a plasmacytoma.
    Bogen B
    Eur J Immunol; 1996 Nov; 26(11):2671-9. PubMed ID: 8921954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-binding IgA myeloma proteins in mice: specificities to antigens containing -D 1 leads to 6 linked galactose side chains and a protein antigen in wheat.
    Potter M; Mushinski EB; Glaudemans CP
    J Immunol; 1972 Feb; 108(2):295-300. PubMed ID: 4114953
    [No Abstract]   [Full Text] [Related]  

  • 11. Homogeneous murine immunolglobulins with anticarbohydrate specificity.
    Glaudemans CP; Das MK; Vrana M
    Methods Enzymol; 1978; 50():316-23. PubMed ID: 661584
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor immunity induced by preimmunization with BALB/c mouse myeloma protein.
    Freedman PM; Autry JR; Tokuda S; Williams RC
    J Natl Cancer Inst; 1976 Apr; 56(4):735-40. PubMed ID: 56452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin-producing tumors and myeloma proteins of mice.
    Potter M
    Physiol Rev; 1972 Jul; 52(3):631-719. PubMed ID: 4555516
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunoreactivity of solid phase hapten binding plasmacytoma protein (ABPC 24).
    Lehtonen OP
    Mol Immunol; 1981 Apr; 18(4):323-9. PubMed ID: 7300833
    [No Abstract]   [Full Text] [Related]  

  • 15. Regulation of myeloma growth in vitro by idiotype-specific T lymphocytes.
    Flood PM; Philipps C; Taupier MA; Schreiber H
    J Immunol; 1980 Jan; 124(1):424-30. PubMed ID: 6965296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myeloma cell immunoglobulin expression during in vivo growth in diffusion chambers: evidence for repetitive cycles of differentiation.
    Rohrer JW; Vasa K; Lynch RG
    J Immunol; 1977 Sep; 119(3):861-6. PubMed ID: 330758
    [No Abstract]   [Full Text] [Related]  

  • 17. Hybridoma produces protective antibodies directed against the sporozoite stage of malaria parasite.
    Yoshida N; Nussenzweig RS; Potocnjak P; Nussenzweig V; Aikawa M
    Science; 1980 Jan; 207(4426):71-3. PubMed ID: 6985745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of immune response to sheep red blood cells on plasmacytoma MOPC 104 E.
    Ghanta VK; Hiramoto NS; Hiramoto RN
    Cancer Res; 1981 Jun; 41(6):2197-9. PubMed ID: 7237419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat x rat hybrid myelomas and a monoclonal anti-Fd portion of mouse IgG.
    Galfrè G; Milstein C; Wright B
    Nature; 1979 Jan; 277(5692):131-3. PubMed ID: 310519
    [No Abstract]   [Full Text] [Related]  

  • 20. Antigenic markers of V domain of mouse MOPC 21 IgG1 L chain. The conformational basis of VL domain markers and content of MOPC 21 VL-like immunoglobulins in sera of inbred mouse strains.
    Rokhlin OV; Petrosyan MN; Ibraghimov AR; Vengerova TI; Bogachova GT
    Eur J Immunol; 1983 May; 13(5):397-403. PubMed ID: 6189726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.